EAPI logo

Euroapi S.A. Stock Price

ENXTPA:EAPI Community·€304.7m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 11 Fair Values set on narratives written by author

EAPI Share Price Performance

€3.20
-0.01 (-0.31%)
3.9% overvalued intrinsic discount
€3.08
Fair Value
€3.20
-0.01 (-0.31%)
3.9% overvalued intrinsic discount
€3.08
Fair Value
Price €3.20
AnalystConsensusTarget €3.08
AnalystLowTarget €2.50
AnalystHighTarget €3.50

EAPI Community Narratives

AnalystConsensusTarget·
Fair Value €3.08 3.9% overvalued intrinsic discount

Capacity Expansion And Biotechnological Processes Will Strengthen API Supply

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AnalystLowTarget·
Fair Value €2.5 28.0% overvalued intrinsic discount

Rising Regulatory And Geopolitical Risks Will Undermine API Profits

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystHighTarget·
Fair Value €3.5 8.6% undervalued intrinsic discount

Green Chemistry And Domestic Sourcing Will Unlock Secular Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
€2.5
28.0% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
-2.04% p.a.
Profit Margin
11.01%
Future PE
3.09x
Share price in 2028
€2.97

Snowflake Analysis

Adequate balance sheet and fair value.

0 Risks
2 Rewards

Euroapi S.A. Key Details

€882.8m

Revenue

€761.8m

Cost of Revenue

€121.0m

Gross Profit

€245.3m

Other Expenses

-€124.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 03, 2026
-1.31
13.71%
-14.08%
5.3%
View Full Analysis

About EAPI

Founded
2020
Employees
3187
CEO
David Seignolle
WebsiteView website
www.euroapi.com/en

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances. It provides their products to pharmaceutical, generic drug manufacturers, animal health product manufacturers, consumer health, nutrition and cosmetic product companies, biotech companies, and distribution companies, as well as contract development and manufacturing organization. Euroapi S.A. was incorporated in 2020 and is based in Paris, France.

Recent EAPI News & Updates

Euroapi (EPA:EAPI) Has Debt But No Earnings; Should You Worry?

Oct 03
Euroapi (EPA:EAPI) Has Debt But No Earnings; Should You Worry?

Recent updates

No updates